Laxmi Dental Limited has informed the Exchange about General Updates

Listed-company acquisitionStrategic Transactions View source PDF Explain this filing

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.3%Reaction day

₹445.00

prior close

₹445.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.5%-5.8% vs market

Medical Equipment & Supplies peers, median of 11sector-0.6%-3.6% vs sector

On the reaction day the stock moved 5.8 pts less than Nifty Microcap 250 and 3.6 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-1.1

15m

-0.7

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.3+1.5-5.8-0.6-3.6

Next day

-3.1+1.8-4.9+0.6-3.6

-4.3+1.1-5.4-1.3-3.0

-7.6-0.5-7.1-0.7-6.9

-5.1+0.0-5.2+2.3-7.5

-7.6-0.3-7.3-0.2-7.4

-9.7-1.7-8.0-1.6-8.2

15d

-21.6+0.1-21.7-0.2-21.4

-23.6-2.9-20.7+5.5-29.1

-28.2-3.0-25.3-1.5-26.7

-29.5+1.0-30.5+7.4-36.9

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laxmi Dental's board approved acquiring a 58% stake (49% equity + 9% CCPS) in IDBG AI Dent Global Private Limited, a DPIIT-recognized AI-dentistry startup, for a total investment of up to ₹2.05 crore. This includes about ₹1.37 crore for 11,175 equity shares and ₹62.88 lakh for 5,123 compulsorily convertible preference shares, both at a premium of ₹1,217.5 per share. AI Dent was incorporated in December 2024, has no revenue history, and works on AI-powered dental imaging and X-ray analysis software. The transaction is at arm's length, not a related-party deal, needs no regulatory approvals, and is expected to close by September 30, 2025. The board also reconstituted its Nomination and Remuneration Committee with three independent directors.

Likely market impact

The deal size is small (₹2.05 crore) relative to a listed company, so the immediate financial impact is minor. However, it signals a strategic push into AI-driven dental technology, which could be a positive long-term growth signal for shareholders if the startup scales successfully.